Acute infective endocarditis is a life threatening disease characterized by the involvement of normal valvular endothelium. The predominant pathogen in this disease is Staphylococcus aureus. It has been theorized that the unique ability of staphylococc to colonize and invade normal valvular endothelium is responsible for this association. In the present proposal S. aureus attachment to endothelial cells will be studied using an in vitro system which simulates the valvular surface colonized by bacteria in acute infective endocarditis. These cells, harvested from human valvular tissue, will be used to explore the surface structures which mediate staphylococcal attachment. The ability of different blood culture isolates to adhere to endothelial cells harvested from different vascular sites will be compared. The number of potential binding sites and the rate of attachment and endocytosis will be investigated. Transmission electron microscopy will be used in morphologic studies which will determine the specificity of endocytosis and the fate of intracellular bacteria. The ability of specific endothelial cell membrane components to bind S. aureus and potentially act as mediators of adherence will be studied. Binding of radiolabelled, solubilized membrane proteins and glycoproteins to S. aureus will be assessed. Solubilized surface membrane proteins and glycoproteins will be further purified and characterized by affinity chromatography. The potential role of these membrane components in staphylococcal adherence will be assessed in competitive adherence assays. In this proposal we will investigate whether selective staphylococcal adherence to normal valvular endothelium contributes to the predominance of this organism as a pathogen in acute endocarditis. These studies will increase our understanding of what remains a life-threatening disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL034171-02
Application #
3346848
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1985-04-01
Project End
1988-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Montefiore Medical Center (Bronx, NY)
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10467
Tompkins, D C; Blackwell, L J; Hatcher, V B et al. (1992) Staphylococcus aureus proteins that bind to human endothelial cells. Infect Immun 60:965-9
Elliott, D A; Hatcher, V B; Lowy, F D (1991) A 220-kilodalton glycoprotein in yeast extract inhibits Staphylococcus aureus adherence to human endothelial cells. Infect Immun 59:2222-3
Tsai, H M; Nagel, R L; Hatcher, V B et al. (1991) The high molecular weight form of endothelial cell von Willebrand factor is released by the regulated pathway. Br J Haematol 79:239-45
Tompkins, D C; Hatcher, V B; Patel, D et al. (1990) A human endothelial cell membrane protein that binds Staphylococcus aureus in vitro. J Clin Invest 85:1248-54
Bengualid, V; Hatcher, V B; Diamond, B et al. (1990) Staphylococcus aureus infection of human endothelial cells potentiates Fc receptor expression. J Immunol 145:4279-83
Blumberg, E A; Hatcher, V B; Lowy, F D (1988) Acidic fibroblast growth factor modulates Staphylococcus aureus adherence to human endothelial cells. Infect Immun 56:1470-4
Lowy, F D; Fant, J; Higgins, L L et al. (1988) Staphylococcus aureus--human endothelial cell interactions. J Ultrastruct Mol Struct Res 98:137-46
Kessler, J A; Conn, G; Hatcher, V B (1986) Isolated plasma membranes regulate neurotransmitter expression and facilitate effects of a soluble brain cholinergic factor. Proc Natl Acad Sci U S A 83:3528-32
Gimenez-Gallego, G; Conn, G; Hatcher, V B et al. (1986) The complete amino acid sequence of human brain-derived acidic fibroblast growth factor. Biochem Biophys Res Commun 138:611-7
Gordon, P B; Zanger, D R; Hatcher, V B (1986) Extracellular matrix proteoglycans and cell-substratum adhesion of human endothelial cells: the effect of methyl beta-D-xylopyranoside. Carbohydr Res 151:121-34

Showing the most recent 10 out of 15 publications